Search results
Results from the WOW.Com Content Network
In Russia, 13 children had been treated (5 with intensive care) by mid-June for a multisystem inflammatory syndrome at the Morozov Children's Hospital in Moscow, including a 2-year-old girl with the COVID-19 infection who died on 23 May following an initial diagnosis of suspected Kawasaki disease. [90]
Breakthrough infections have been identified in individuals immunized against a variety of diseases including mumps, varicella , influenza, and COVID-19. [2] [3] [4] The characteristics of the breakthrough infection are dependent on the virus itself. Often, infection of the vaccinated individual results in milder symptoms and shorter duration ...
Significantly more children reported severe anxiety and severe sleep-related impairment during the COVID-19 lockdown than before COVID-19. The results of this study confirm the suspicions of child and youth care professionals that the COVID-19 lockdown has negative effects on the mental and social health of children and adolescents.
The COVID-19 pandemic has had many impacts on global health beyond those caused by the COVID-19 disease itself. It has led to a reduction in hospital visits for other reasons. There have been 38 per cent fewer hospital visits for heart attack symptoms in the United States and 40 per cent fewer in Spain. [1]
The mumps virus was first identified as the cause of mumps in 1934 and was first isolated in 1945. Within a few years after isolation, vaccines protecting against MuV infection had been developed. MuV was first recognized as a species in 1971, and it has been given the scientific name Mumps orthorubulavirus .
The condition is an infectious disease caused by the Coccidioides fungus that grows in the soil and dirt in some areas of the U.S. and other parts of the world, according to the Centers for ...
The reasoning is because in the 20-29 age range the benefits to individual of vaccination were less as their likelihood of harm from COVID‑19 is less and closer to the potential risk of harm from the vaccine (at a medium exposure risk with COVID‑19 infection cases running at a rate of 60 per 100,000).
The COVID-19 vaccines are widely credited for their role in reducing the severity and death caused by COVID-19. [128] [129] As of March 2023, more than 5.5 billion people had received one or more doses [130] (11.8 billion in total) in over 197 countries. The Oxford-AstraZeneca vaccine was the most widely used. [131]